21 Jul 2021 --- Blue California and Massachusetts-based biotech company Conagen are on the path to commercialization for fermentation-derived nicotinamide mononucleotide (NMN). This high-purity, nature-based metabolic component has caught the attention of health-conscious consumers for supporting energy and longevity.
